Providing actionable real-world evidence to support patients, clinicians, and policymakers in decision making.
CREST develops real-world evidence on the health effects of medications and other medical products, and prepares the next generation of pharmacoepidemiology leaders.
Explore the latest research from CREST investigators.
In a recent interview, Dr. Sean Hennessy highlights how scientific evidence and advocacy can drive FDA label changes that expand access to safe, effective medications.
Penn researchers have received NIH/NIBIB funding to develop robust and interpretable multi-modal AI models that integrate genomics, imaging, and electronic health data to advance cancer and Alzheimer’s disease research.
Rising temperatures pose serious risks for people with type 2 diabetes, increasing the likelihood of heat exhaustion, blood sugar fluctuations, and cardiac issues. Charles Leonard, PharmD, MSCE, FISPE addresses these health threats with Yale Climate Connections.